- Home
- PLTR vs ABT Comparison
PLTR vs ABT Comparison
Compare PLTR & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTR
- ABT
- Stock Information
- Founded
- PLTR 2003
- ABT 1888
- Country
- PLTR United States
- ABT United States
- Employees
- PLTR N/A
- ABT N/A
- Industry
- PLTR Retail: Computer Software & Peripheral Equipment
- ABT Medical/Dental Instruments
- Sector
- PLTR Technology
- ABT Health Care
- Exchange
- PLTR Nasdaq
- ABT Nasdaq
- Market Cap
- PLTR 252.5B
- ABT 221.0B
- IPO Year
- PLTR 2020
- ABT N/A
- Fundamental
- Price
- PLTR $101.39
- ABT $134.94
- Analyst Decision
- PLTR Hold
- ABT Buy
- Analyst Count
- PLTR 20
- ABT 17
- Target Price
- PLTR $78.28
- ABT $131.41
- AVG Volume (30 Days)
- PLTR 105.0M
- ABT 6.5M
- Earning Date
- PLTR 02-03-2025
- ABT 04-16-2025
- Dividend Yield
- PLTR N/A
- ABT 1.75%
- EPS Growth
- PLTR 111.11
- ABT 134.36
- EPS
- PLTR 0.19
- ABT 7.64
- Revenue
- PLTR $2,865,507,000.00
- ABT $41,950,000,000.00
- Revenue This Year
- PLTR $32.54
- ABT $6.71
- Revenue Next Year
- PLTR $26.33
- ABT $7.45
- P/E Ratio
- PLTR $533.63
- ABT $17.70
- Revenue Growth
- PLTR 28.79
- ABT 4.59
- 52 Week Low
- PLTR $20.33
- ABT $99.71
- 52 Week High
- PLTR $125.41
- ABT $135.41
- Technical
- Relative Strength Index (RSI)
- PLTR 52.87
- ABT 71.01
- Support Level
- PLTR $95.80
- ABT $128.25
- Resistance Level
- PLTR $125.41
- ABT $132.65
- Average True Range (ATR)
- PLTR 7.62
- ABT 2.43
- MACD
- PLTR -0.85
- ABT -0.02
- Stochastic Oscillator
- PLTR 48.83
- ABT 95.01
About PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.